2019 Annual Meeting | C69 - The Palliative Care Guide in Neurology: Best Practice in Communication, Advance Care Planning, and End-of-life Care of Patients with Brain Tumors and Other Life-limiting Neurological Disorders

Date Sunday 05/05/19

Time 03:30 PM - 05:30 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Tobias Walbert, MD, PhD, FAAN

Topic(s) Neuro-oncology, Pain

Learning Objectives Participants should be able to communicate a serious diagnosis to a patient in an honest yet compassionate manner, identify the key components of palliative care and hospice, discuss end-of-life issues with patients and assist them in developing advance directives, and manage the palliative care needs of a patient with brain tumors.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge

Program Level Introductory

Program Tracks Neurohospitalist

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:35 PM EDT	Introduction	Introduction Tobias Walbert, MD, PhD, FAAN
03:35 PM - 04:15 PM EDT	Speaker	The Role of Hospice and Palliative Care: Advance Care Planning in Neurology Tobias Walbert, MD, PhD, FAAN
04:15 PM - 05:05 PM EDT	Speaker	Communication Strategies for Clinicians Caring for Patients and Families Coping with Advanced Neurological Disease Deborah Forst, MD
05:05 PM - 05:30 PM EDT	Q&A	Questions and Answers Tobias Walbert, MD, PhD, FAAN

Faculty Disclosures
Tobias Walbert, MD, PhD, FAAN	Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AnHeart.
Deborah Forst, MD	Dr. Forst has stock in Eli Lilly. Dr. Forst has received research support from Conquer Cancer Foundation of the American Society of Clinical Oncology. Dr. Forst has received research support from Palliative Care Research Cooperative Group. Dr. Forst has received research support from American Cancer Society Institutional Research Grant.

��ɫ��

��ɫ��